Jennifer Barrett, Assistant Editor

At the American Academy of Pain Medicine’s 2017 Annual Meeting, survey results were presented that revealed the implications of naloxone use in real-world experiences with the recently approved intranasal naloxone formulation.

An investigational Ebola vaccine showed promising results in an early-stage study, in which an induced immune response persisted in adult participants for nearly 1 year after receiving the vaccination.

The FDA has issued a warning regarding the drug Viberzi (eluxadoline), which is used to treat irritable bowel syndrome with diarrhea (IBS-D).

Merck has announced the FDA’s approval of Keytruda’s indication for treatment in classical Hodgkin lymphoma (cHL) patients.

The FDA has approved Novartis’ Kisqali (ribociclib), in combination with an aromatase inhibitor as initial endocrine-based therapy treatment, for the treatment of breast cancer.

A recent study investigated parental attitudes toward their child receiving a flu vaccine and its negative influence on vaccination rates.

A recently published study finds that maternal folic acid levels could have an effect on a child’s blood pressure.

New research conducted by the London Metropolitan University suggests that patients may be able to follow a reduced carb diet as an effective and safe strategy for managing their diabetes.

The FDA has accepted Allergan’s supplemental new drug application (sNDA) for Vraylar (cariprazine).

Glassdoor released its third annual list of the highest-paying professions in the United States, and both pharmacists and pharmacy managers landed among the top 25 jobs highlighted.

In a nationwide survey conducted by the Consumer Healthcare Products Association Educational Foundation, a larger portion of acetaminophen users in the United States reported knowing how to use the drug safely and effectively while avoiding potential risks.

Younger women are less likely to be screened for cardiovascular disease (CVD) and treated with preventive medicine than men, a recent study found.

TG Therapeutics’ investigational combination leukemia drug TG-1101 (ubilituximab), used with approved treatment Imbruvica (ibrutinib), showed positive results in a late-stage clinical trial.

The FDA announced approval of Noctiva (desmopressin acetate).

A bad influenza season might call for higher-dose flu vaccines in older adults.

Young individuals with type 2 diabetes are more likely to develop condition-related complications than their type 1 counterparts.

Several members of Congress are gearing up to address high prescription drug prices in the wake of President Trump’s promise to crack down on the pharmaceutical industry.

Senior Executives with Insulet Corporation recently announced their milestone of achieving 100,000 active users worldwide of the Omnipod® Insulin Management System.

President Trump delivered his first presidential address to a joint session of Congress on Tuesday.

Baxter International and ScinoPharm Taiwan have teamed up in a strategic partnership to develop, manufacture, and commercialize generic oncology injectables, according to a press release.

Federal authorities are aiming investigative efforts at Department of Veterans Affairs (VA) medical centers to curb an increase in drug diversion acts committed in some VA hospitals.

The FDA has approved a drug for the treatment of carcinoid syndrome diarrhea.

The FDA has approved AstraZeneca’s fixed-dose combination drug, Qtern (10 mg dapagliflozin and 5 mg saxagliptin), for the treatment of type 2 diabetes as an adjunct to diet and exercise.

Endo Pharmaceuticals has voluntarily recalled 1 lot of its Edex (alprostadil for injection) 10 mcg due to lack of sterility assurance, according to an FDA press release.

Young children had more than twice the risk for overdose compared to children whose mothers were prescribed nonsteroidal anti-inflammatory drugs (NSAIDs) rather than opioids.

A Louisiana drug and dietary supplement maker was ordered to cease operations for failing to comply with federal laws, according to a press release from the FDA.

Children have an increased chance of drug overdose when their mothers are prescribed opioids, a study published in Pediatrics reports.

The FDA has accepted Novartis’ supplemental new drug application (sNDA) for filing and granted priority review for the expanded use of a new cancer drug.

The American Diabetes Association (ADA) released their first position statement in 15 years regarding diabetic retinopathy.

The FDA has accepted Pfizer’s biologics license application (BLA) and granted priority review for their experimental leukemia treatment.